Devin W. Steenkamp, MBChB
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MBChB, University of Pretoria




Devin Steenkamp is an academic diabetologist with a focus on type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program at Boston Medical Center and Boston University School of Medicine and his clinical practice is focused on the use of diabetes technologies in care. In addition, he is the principal investigator on a variety of clinical trials related to diabetes pharmacotherapy and the application of novel diabetes technologies.

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research





FOCUS - Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
07/01/2019 - 07/31/2024 (PI)
Novo Nordisk

SWITCH Pro: A randomised, cross-over, open-label, multi-centre trial comparing the effect of…
09/23/2018 - 09/23/2021 (PI)
Novo Nordisk

MYL-1601D-3001 A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the…
02/15/2019 - 02/27/2021 (PI)
Mylan GmbH

Protocol NN9924-4223
07/27/2016 - 07/27/2019 (PI)
Novo Nordisk

A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Commparing the Efficacy…
03/06/2018 - 12/31/2018 (PI)
Mylan GmbH

Exploring preserved proinsulin secretion in long standing type 1 diabetes
02/01/2016 - 08/31/2017 (PI)
Helmsley Charitable Trust

Glycemla Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
08/01/2014 - 07/31/2016 (PI)
Mass General Hosp NIH-NIDDK


Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Pinardo H, Rubin SJ, Hashemi S, DePietro J, Pearce EN, Ananthakrishnan S, Alexanian SM, Steenkamp DW, Noordzij JP. The use of vitamin D in preventing post-thyroidectomy hypocalcemia: An endocrinologist survey study. Clin Endocrinol (Oxf). 2020 May 29.View Related Profiles. PMID: 32469425
     
  2. Modzelewski KL, Fantasia KL, Steenkamp DW. Reconsidering Meaningful Outcomes in Diabetes mHealth Research. US Endocrinology. 2019; 2(15):74-76. View Publication
  3. Fantasia KL, Steenkamp DW. Optimal Glycemic Control in a Patient With HNF1A MODY With GLP-1 RA Monotherapy: Implications for Future Therapy. J Endocr Soc. 2019 Dec 01; 3(12):2286-2289. PMID: 31737858; DOI: 10.1210/js.2019-00278;
     
  4. Steenkamp D. CONTINUOUS GLUCOSE MONITORING AS A HYPOGLYCEMIA MITIGATION TOOL IN INDIVIDUALS WITH TYPE 1 DIABETES WITH IMPAIRED HYPOGLYCEMIC AWARENESS. Endocr Pract. 2019 Jun; 25(6):619-621. PMID: 31242124; DOI: 10.4158/EP-2019-0100;
     
  5. Steenkamp DW, Cacicedo JM, Sullivan CA. Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264. Diabetes Care. 2019 05; 42(5):e84.View Related Profiles. PMID: 31010951; DOI: 10.2337/dc19-0158;
     
  6. Stockman MC, Modzelewski K, Steenkamp D. Mobile Health and Technology Usage by Patients in the Diabetes, Nutrition, and Weight Management Clinic at an Urban Academic Medical Center. Diabetes Technol Ther. 2019 07; 21(7):400-405.View Related Profiles. PMID: 31045447; DOI: 10.1089/dia.2018.0369;
     
  7. Fantasia K, Modzelewski K, Steenkamp D. Predictive Glucose Trends From Continuous Glucose Monitoring: Friend or Foe in Clinical Decision Making? J Diabetes Sci Technol. 2019 09; 13(5):963-966.View Related Profiles. PMID: 30636438
     
  8. Sullivan CA, Cacicedo JM, Rajendran I, Steenkamp DW. Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study. PLoS One. 2018; 13(11):e0207065.View Related Profiles. PMID: 30412637; DOI: 10.1371/journal.pone.0207065;
     
  9. Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240.View Related Profiles. PMID: 29957042
     
  10. Jones Iv AR, Coleman EL, Husni NR, Deeney JT, Raval F, Steenkamp D, Dooms H, Nikolajczyk BS, Corkey BE. Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells. PLoS One. 2017; 12(12):e0188474.View Related Profiles. PMID: 29206239; DOI: 10.1371/journal.pone.0188474;
     
Showing 10 of 34 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 34 publications over 9 distinct years, with a maximum of 9 publications in 2017

YearPublications
20111
20134
20145
20152
20164
20179
20182
20196
20201

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Type 1 Diabetes Mellitus
Proinsulin C Peptide
MODY

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
Contact for Mentoring:

720 Harrison Avenue ((DOB-Doctors Office Building)
Boston MA 02118
Google Map


Steenkamp's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department